Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $22.6700 (0%) ($22.0800 - $23.2000) on Wed. Jul. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.57% (three month average) | RSI | 74 | Latest Price | $22.6700(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1% a day on average for past five trading days. | Weekly Trend | TGTX advances 10.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(64%) ARKG(59%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -3.285% in a week (0% probabilities). VIXM(-34%) VXX(-32%) UUP(-17%) DRIV(-4%) XLC(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.285% (StdDev 6.57%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
5 Day Moving Average | $23.01(-1.48%) | 10 Day Moving Average | $22.29(1.7%) | 20 Day Moving Average | $20.65(9.78%) | To recent high | -6.1% | To recent low | 119.7% | Market Cap | $2.871b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |